Rosiglitazone diabetes drug molecule

Rosiglitazone diabetes drug molecule

A624/0460 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 34.1MB

Downloadable file size: 427.9KB

Price image Pricing

Please login to use the price calculator


Caption: Rosiglitazone diabetes drug molecule. Computer model of a molecule of the diabetes drug rosiglitazone. Atoms are represented as rods and are colour-coded: carbon (blue), hydrogen (white), oxygen (yellow), nitrogen (pink) and sulphur (green). Rosiglitazone, which is marketed under the name Avandia, belongs to a group of drugs known as thiazolidinediones that are used to treat type II diabetes. Rosiglitazone controls blood sugar levels by reducing the production and secretion of glucose by the liver and increasing the body's sensitivity to insulin, the hormone that regulates blood glucose levels. It requires that some insulin is produced by the pancreas and so cannot be used to treat type I diabetes.

Release details: Model release not required. Property release not required.

Keywords: anti-diabetic, antihyperglycemic agent, artwork, avandia, biochemical, biochemistry, blood glucose level, blood sugar level, chemical, chemistry, compound, compounds, computer artwork, computer model, diabetes, drug, illustration, insulin sensitiser, medical, medicine, molecular, molecule, molecules, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, rod, rods, rosiglitazone, single, structure, thiazolidinedione, type 2, type ii

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.